AVBP NASDAQ
ArriVent BioPharma, Inc. Common Stock
1W: -5.0%
1M: -12.6%
3M: +17.4%
YTD: +29.8%
1Y: +29.4%
$26.73
-0.27 (-1.00%)
Weekly Expected Move ±4.9%
$25
$27
$28
$29
$31
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-145M
Net Income
-14.0% YoY
$-134M
Free Cash Flow
-12.4% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-51.4%
ROA-47.8%
ROIC2219.8%
Valuation
P/E-8.3
P/B3.7
EV/EBITDA-4.8
Leverage
Debt/Equity0.00
Current Ratio12.83
Interest Cov.0.0x
Quality Scores
Piotroski F2/9
Altman Z21.95
Beneish M0.00